Review Articles
1. Altered immunity as a risk factor for non-Hodgkin lymphoma.
- Author
- Grulich AE; Vajdic CM; Cozen W;
- Institution
- National Centre in HIV Epidemiology and Clinical Research, Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia. agrulich@nchecr.unsw.edu.au
- Journal
- Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):405-8. Epub 2007 Mar 2.
- Abstract URL
- Click here to view abstract
2. Primary CNS lymphoma.
- Author
- Batchelor T; Loeffler JS;
- Institution
- Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. tbatchelor@partners.org
- Journal
- J Clin Oncol. 2006 Mar 10;24(8):1281-8.
- Abstract URL
- Click here to view abstract
3. Coeliac disease and lymphoma.
- Author
- Kumar P;
- Institution
- Adult & Paediatric Gastroenterology, Barts & London Medical School, London, UK. p.j.kumar@qmul.ac.uk
- Journal
- Eur J Gastroenterol Hepatol. 2006 Feb;18(2):131-2.
4. Novel treatment strategies for aggressive non-Hodgkin's lymphoma.
- Author
- Fayad L; Younes A;
- Institution
- Department of Lymphoma/Myeloma, University of Texas, MD Anderson Cancer Center, Box # 429, Houston, TX 77030, USA.
- Journal
- Expert Opin Pharmacother. 2006 Apr;7(6):733-48.
- Abstract URL
- Click here to view abstract
5. Cure of incurable lymphoma.
- Author
- DeNardo GL; Sysko VV; DeNardo SJ;
- Institution
- Radiodiagnosis and Therapy, Division of Hematology/Oncology, University of California Davis Medical Center, Sacramento, CA, USA. gldenardo@ucdavis.edu
- Journal
- Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S46-56.
- Abstract URL
- Click here to view abstract
6. Logistics of therapy with the ibritumomab tiuxetan regimen.
- Author
- Meredith RF;
- Institution
- Department of Radiation Oncology, University of Alabama Medical Center, Birmingham, AL, USA. rmeredith@uabmc.edu
- Journal
- Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S35-8.
- Abstract URL
- Click here to view abstract
7. Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
- Author
- Meredith RF;
- Institution
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. rmeredith@uabmc.edu
- Journal
- Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S23-9.
- Abstract URL
- Click here to view abstract
8. Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma.
- Author
- Friedberg JW; Freedman AS;
- Institution
- James P. Wilmot Cancer Center, University of Rochester, 601 Elmwood Avenue, Box 704, Room 1-4118C, NY 14642, USA. jonathan_friedberg@urmc.rochester.edu
- Journal
- Curr Treat Options Oncol. 2006 Jul;7(4):276-84.
- Abstract URL
- Click here to view abstract
9. Primary intraocular lymphoma: A review.
- Author
- Choi JY; Kafkala C; Foster CS;
- Institution
- Retina Specialists of Boston, Cambridge, MA, USA.
- Journal
- Semin Ophthalmol. 2006 Jul-Sep;21(3):125-33.
- Abstract URL
- Click here to view abstract
10. The role of PET in lymphoma.
- Author
- Jhanwar YS; Straus DJ;
- Institution
- Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
- Journal
- J Nucl Med. 2006 Aug;47(8):1326-34.
- Abstract URL
- Click here to view abstract
Previous Section
